Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BRIEF-Travere Therapeutics Q3 EPS USD -0.55

BRIEF-Travere Therapeutics Q3 EPS USD -0.55

ReutersReuters2026/11/02 21:02

Nov 02 (Reuters) - Travere Therapeutics Q3 net income USD -52.337 million.

  • Q3 operating income USD -68.105 million
  • Q3 product sales USD 220.196 million
  • Q3 operating expenses USD 292.668 million
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!